Screener
KEMX vs KURE
KraneShares MSCI Emerging Markets ex China Index ETF vs KraneShares MSCI All China Health Care Index ETF
Key differences
- KEMX costs 0.41% less per year.
- Over the last 3 years, KEMX has delivered higher annualized returns.
Side-by-side comparison
| KEMX | KURE | |
|---|---|---|
| Annual cost (TER) | 0.24% | 0.65% |
| Fund size (AUM) | $118M | $82M |
| Since | 2019 | 2018 |
| Dividend yield | 2.67% | 4.14% |
| Asset class | equity | equity |
| Region | — | emerging markets |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +66.1% | +4.6% |
| CAGR 3Y | +27.6% | -5.4% |
| CAGR 5Y | +13.2% | -14.8% |
| Sharpe 3Y | 1.23 | -0.16 |
| Volatility 1Y | 21.87% | 26.26% |
| Max drawdown | -38.80% | -68.53% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to KEMX and KURE
Explore further